{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:16:38Z","timestamp":1783044998332,"version":"3.54.6"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Home medical care provision has become more significant as the Japanese population continues to age. However, the number of patients with end-stage pancreatic cancer receiving home medical care remains limited, regardless of the patients\u2019 strong preference for home medical care. Additionally, prognostic prediction in patients with end-stage pancreatic cancer receiving home medical care is not well validated, which limits the ability of clinicians to plan effective palliative interventions. Therefore, in this study, we aimed to identify the prognostic factors associated with overall survival (OS) in patients with end-stage pancreatic cancer receiving home medical care and to develop a new prognostic scoring system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This nine-center, retrospective study included patients with end-stage pancreatic cancer who were treated with home medical care between 2021 and 2025 in Japan. Univariate and multivariate analyses were performed to identify independent prognostic factors associated with OS. A prognostic scoring system was developed based on the factors identified in the multivariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 168 (76 male and 92 female) participants were included in this study. The median OS with home medical care was 30 days. Multivariate analysis revealed that a history of opioid use before the initiation of home medical care, the presence of peritoneal dissemination, and a modified Glasgow Prognostic Score (mGPS) of 2 were independently associated with poor OS at home. Stratification based on the above factors demonstrated that patients presenting with two or more risk factors had significantly worse home survival than did those with one or no risk factors (24 versus 45 days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identified prior opioid use, peritoneal dissemination, and a mGPS of 2 as independent risk factors for OS in patients with end-stage pancreatic cancer receiving home medical care. These results indicate that assessing these factors may aid healthcare providers in making informed decisions and optimizing supportive care strategies tailored to patient prognosis in the home medical care setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-026-02015-1","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:33:53Z","timestamp":1778477633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognosis prediction for end-stage pancreatic cancer with home medical care: A retrospective cohort study conducted at multiple institutions in Hiroshima"],"prefix":"10.1186","volume":"25","author":[{"given":"Hiroaki","family":"Yamane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsushi","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2015_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1378\/chest.119.2.364","volume":"119","author":"E Farrero","year":"2001","unstructured":"Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F. Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy. Chest. 2001;119:364\u20139.","journal-title":"Chest"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0733464811408699","volume":"32","author":"L Funk","year":"2013","unstructured":"Funk L, Stajduhar K. Analysis and proposed model of family caregivers\u2019 relationships with home health providers and perceptions of the quality of formal services. J Appl Gerontol. 2013;32:188\u2013206.","journal-title":"J Appl Gerontol"},{"key":"2015_CR3","doi-asserted-by":"publisher","first-page":"e27225","DOI":"10.1097\/MD.0000000000027225","volume":"100","author":"M Kosaka","year":"2021","unstructured":"Kosaka M, Miyatake H, Kotera Y, Masunaga H, Arita S, Tsunetoshi C, et al. The survival time of end-of-life home care patients in Fukui prefecture, japan: A retrospective observational study. Med (Baltim). 2021;100:e27225.","journal-title":"Med (Baltim)"},{"key":"2015_CR4","first-page":"137","volume":"6","author":"H Yamane","year":"2025","unstructured":"Yamane H, Yoshimitsu A, Akimoto E, Abe T, Yamane M. Real-world insights: end-of-life care for patients with terminal gastric cancer at home. Palliat Med Rep. 2025;6:137\u201343.","journal-title":"Palliat Med Rep"},{"key":"2015_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2015_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.ejso.2018.04.022","volume":"44","author":"T Abe","year":"2018","unstructured":"Abe T, Amano H, Kobayashi T, Hanada K, Nakahara M, Ohdan H, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2018;44:1573\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"2015_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/hepr.12597","volume":"46","author":"T Abe","year":"2016","unstructured":"Abe T, Tashiro H, Hattori M, Kuroda S, Tahara H, Ohira M, et al. Prediction of long-term survival by using the Glasgow prognostic score in patients with hepatocellular carcinoma after liver transplantation. Hepatol Res. 2016;46:622\u201333.","journal-title":"Hepatol Res"},{"key":"2015_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12935-020-01558-4","volume":"20","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ren D, Jin X, Wu H. The prognostic value of modified Glasgow prognostic score in pancreatic cancer: a meta-analysis. Cancer Cell Int. 2020;20:462.","journal-title":"Cancer Cell Int"},{"key":"2015_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/S0714980822000125","volume":"42","author":"CL Sheppard","year":"2023","unstructured":"Sheppard CL, Kwon C, Yau M, Rios J, Austen A, Hitzig SL. Aging in place in social housing: a scoping review of social housing for older adults. Can J Aging. 2023;42:69\u201379.","journal-title":"Can J Aging"},{"key":"2015_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1470-2045(17)30438-2","volume":"18","author":"B O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C, et al. The TNM classification of malignant tumours-towards common Understanding and reasonable expectations. Lancet Oncol. 2017;18:849\u201351.","journal-title":"Lancet Oncol"},{"key":"2015_CR11","first-page":"1973","volume":"27","author":"D Hui","year":"2019","unstructured":"Hui D, Paiva CE, Del Fabbro EG, Steer C, Naberhuis J, van de Wetering M, et al. Prognostication in advanced cancer: update and directions for future research. Support Care Cancer. 2019;27:1973\u201384.","journal-title":"Support Care Cancer"},{"key":"2015_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40425-018-0383-1","volume":"16","author":"M Capne","year":"2018","unstructured":"Capne M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, et al. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab\u3002J. Immunother Cancer. 2018;16:74.","journal-title":"Immunother Cancer"},{"key":"2015_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/jpm.2010.0031","volume":"13","author":"I Bengoechea","year":"2010","unstructured":"Bengoechea I, Gutierrez SG, Vrotsou K, Onaindia MJ, Lopez JM. Opioid use at the end of life and survival in a hospital at home unit. J Palliat Med. 2010;13:1079\u201383.","journal-title":"J Palliat Med"},{"key":"2015_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/cam4.459","volume":"4","author":"RD Peixoto","year":"2015","unstructured":"Peixoto RD, Speers C, McGahan CE, Renouf DJ, Schaeffer DF, Kennecke HF. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. Cancer Med. 2015;4:1171\u20137.","journal-title":"Cancer Med"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-026-02015-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-02015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-02015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:24:01Z","timestamp":1783041841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12904-026-02015-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1186\/s12904-026-02015-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7243989\/v1","asserted-by":"object"}]},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Medical Governance Research Institute, Japan (approval number: MG2024-02-R2). The Medical Governance Research Institute is an independent ethics review organization located in Japan and was responsible solely for the ethical review and approval of this study. The study was not conducted at a university, and Hiroshima University had no role in data collection, analysis, or interpretation, apart from ethical oversight. The requirement for individual informed consent was waived using an opt-out method. All procedures performed in this study were conducted in accordance with the Declaration of Helsinki and relevant national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}